Close Menu

Petri People

What better way to study a disease than by looking at cells from a patient? Researchers are using induced pluripotent stem cell technology to generate cells from patients with Parkinson's disease, diabetes, and Down syndrome, among others, Technology Review's Emily Singer reports. "By differentiating these cells into the cell type affected in the disease, scientists can search for molecular missteps unique to these cells," Singer says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.